These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18699977)

  • 61. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
    Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
    J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD).
    Savarino E; Zentilin P; Marabotto E; Bodini G; Della Coletta M; Frazzoni M; de Bortoli N; Martinucci I; Tolone S; Pellegatta G; Savarino V
    Expert Opin Pharmacother; 2017 Sep; 18(13):1333-1343. PubMed ID: 28754071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population.
    Doan QV; Lange SM; Elfant A; Aguilar D; Reyes E; Lynn RB; Dubois RW
    J Med Econ; 2008; 11(1):23-40. PubMed ID: 19450108
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Prokinetics in childhood].
    Gottrand F
    Arch Pediatr; 2010 Jun; 17(6):737-8. PubMed ID: 20654867
    [No Abstract]   [Full Text] [Related]  

  • 65. [Diagnosis and treatment of gastroesophageal reflux disease].
    Trukhmanov AS
    Ter Arkh; 2011; 83(8):44-8. PubMed ID: 21961332
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Noncardiac chest pain.
    Katz PO
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S32-9. PubMed ID: 17710075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Anorexia nervosa or somatic disease].
    García Aroca J; Alonso Calderón JL; García Redondo C; Rollán Villamarín V
    Cir Pediatr; 2001 Jul; 14(3):98-102. PubMed ID: 11547640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacologic management and treatment of gastroesophageal reflux disease.
    Storr M; Meining A
    Dis Esophagus; 2004; 17(3):197-204. PubMed ID: 15361091
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosis and treatment of gastroesophageal reflux disease in infants and children.
    Vandenplas Y
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():26D-34D. PubMed ID: 11110609
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gastro-oesophageal reflux disease.
    Sifrim D; Lundell L; Zerbib F
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):757-8. PubMed ID: 21126690
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A new prokinetic drug cisapride: pharmacological properties and clinical potential].
    Sheptulin AA; Muradov NN
    Klin Med (Mosk); 1997; 75(7):53-6. PubMed ID: 9411058
    [No Abstract]   [Full Text] [Related]  

  • 74. Review article: gastro-oesophageal reflux disease and psychological comorbidity.
    Mizyed I; Fass SS; Fass R
    Aliment Pharmacol Ther; 2009 Feb; 29(4):351-8. PubMed ID: 19035971
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
    Beaumont H; Boeckxstaens GE
    Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reflux inhibitors: a new approach for GERD?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies.
    El-Serag H; Becher A; Jones R
    Aliment Pharmacol Ther; 2010 Sep; 32(6):720-37. PubMed ID: 20662774
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
    Moayyedi P
    Digestion; 2008; 78 Suppl 1():61-9. PubMed ID: 18832842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.